Randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in Europe, Australia, and New Zealand.
about
Tirilazad for aneurysmal subarachnoid haemorrhageEarly brain injury, an evolving frontier in subarachnoid hemorrhage researchTransition of research focus from vasospasm to early brain injury after subarachnoid hemorrhageAntioxidants: The new frontier for translational research in cerebroprotectionThe importance of early brain injury after subarachnoid hemorrhageMicrodialytical monitoring of uric and ascorbic acids in the brains of patients after severe brain injury and during neurovascular surgeryClinical outcome prediction in aneurysmal subarachnoid hemorrhage using Bayesian neural networks with fuzzy logic inferences.Role of animal studies in the design of clinical trialsAntioxidant therapies for traumatic brain injury.Mechanisms of gender-linked ischemic brain injury.Sex differences in minocycline-induced neuroprotection after experimental strokeIn vivo animal models of cerebral vasospasm: a review.Novel agents in the therapy of endotoxic shock.Adenosine monophosphate activated protein kinase inhibition is protective in both sexes after experimental stroke.Review of medical prevention of vasospasm after aneurysmal subarachnoid hemorrhage: a problem of neurointensive care.Metamorphosis of subarachnoid hemorrhage research: from delayed vasospasm to early brain injuryCerebral Vasospasm in Critically III Patients with Aneurysmal Subarachnoid Hemorrhage: Does the Evidence Support the Ever-Growing List of Potential Pharmacotherapy Interventions?Lower incidence of cerebral infarction correlates with improved functional outcome after aneurysmal subarachnoid hemorrhage.Pharmacological treatment of delayed cerebral ischemia and vasospasm in subarachnoid hemorrhage.Antioxidant strategies in neurocritical careNeuroprotection in subarachnoid hemorrhageEndovascular treatment of subarachnoid hemorrhage.Timing of surgery in patients with aneurysmal subarachnoid haemorrhage: rebleeding is still the major cause of poor outcome in neurosurgical units that aim at early surgery.Cerebral vasospasm after aneurysmal subarachnoid hemorrhage: an overview of pharmacologic management.Bilirubin oxidation products (BOXes) and their role in cerebral vasospasm after subarachnoid hemorrhage.Clinical review: Prevention and therapy of vasospasm in subarachnoid hemorrhageThe Role of GDC Embolization as a Second Choice in the Treatment of Ruptured Cerebral Aneurysm. Retrospective Analysis from Mid-Term Outcome.Current advances in the diagnosis of vasospasm.Clinical trials in cardiac arrest and subarachnoid hemorrhage: lessons from the past and ideas for the future.Medical Management of Cerebral Vasospasm following Aneurysmal Subarachnoid Hemorrhage: A Review of Current and Emerging Therapeutic Interventions.Delayed ischemia after subarachnoid hemorrhage: result of vasospasm alone or a broader vasculopathy?Clinical outcome prediction in aneurysmal subarachnoid hemorrhage - Alterations in brain-body interface.Medical management of patients with aneurysmal subarachnoid haemorrhage.Oxidative stress in subarachnoid haemorrhage: significance in acute brain injury and vasospasm.Management of aneurysmal subarachnoid hemorrhage: State of the art and future perspectives.Controversies and evolving new mechanisms in subarachnoid hemorrhage.Effect of pharmaceutical treatment on vasospasm, delayed cerebral ischemia, and clinical outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.Novel therapeutic strategies for traumatic brain injury: acute antioxidant reinforcement.The pathophysiology and treatment of delayed cerebral ischaemia following subarachnoid haemorrhage.Nimodipine Dose Reductions in the Treatment of Patients with Aneurysmal Subarachnoid Hemorrhage.
P2860
Q24240010-69B63CF8-7B96-4952-9F99-4E185874DFF3Q26823982-89C8DCDF-700D-49B6-9A50-E465141870EEQ26825343-AA82202E-3436-45CF-880D-BFF12B0E1EDBQ26863595-7022AE9C-ECED-49FB-AE70-362AA1369FC9Q27028040-0B5E2351-8BB4-40A8-B534-AC67B21DD062Q28344291-3695454D-5CCE-477D-8459-D90717775551Q30419248-2ED7A00F-C94A-4F91-807F-FB9C1FE97791Q33609005-01AFF7F8-EDA2-418F-BD97-33403F941D32Q33637858-267A2B70-34BC-4BEC-A790-4055ED7253E6Q33681034-27967148-C0A5-4CC8-9358-AAA43CE004C5Q33794484-B635CD92-2C68-4417-BB4D-D362E7CCD55AQ33848030-E21C95EA-2F97-4F51-91E7-3DBBDABE12D9Q34074915-C5333647-CA16-45EE-943A-BEA4B5EBA1CEQ34118392-5104EC29-7F1B-4A26-A796-09B732C3F3C5Q34163182-20018CEB-54B7-43F0-A8CA-03FAD0522188Q34504672-982E47AE-678D-4E32-96DB-7A02147B7ABEQ34612924-C84A4244-2B80-4245-B443-3951E7FD16E9Q35108572-35677A8D-2A15-42AA-A00B-2E8D0D81D978Q35574105-7F690A32-654F-4A3A-A94C-28776313F1A0Q35729668-3A3B1257-0960-4AB1-B5EB-F19303A92AC6Q36034824-2A2FEDB1-0AED-4B89-9A68-034CEDA22C19Q36273747-4C436CFF-B442-4172-A3C3-D9F32A539C18Q36317280-FB9A5A2F-DC14-4577-B581-091A4890B235Q36390897-61187ECC-2E53-4AB7-847E-95FFCFC42026Q36391810-88D018FA-F43B-402D-B307-C028CDA819B7Q36392740-89544F56-3FCD-481A-850D-5DD2A0B719F3Q36557671-32FD0756-672A-4DAC-BF1C-8416D1777A8AQ36681459-11800843-5882-4071-A7BF-0BB8A0C702B1Q36711857-7F861B49-2CDE-444D-A78D-1C2562AEAD26Q36831190-3B1C7735-97A8-495B-A25D-2E775E59A786Q36937589-F43A1936-511A-42C7-BBDA-674B0C92CC73Q37170234-3D60DF80-13D5-4167-806D-6D432A5DBC25Q37244421-16BEE403-932E-4706-A681-BC0652212BB8Q37345850-0E89D431-E977-44B6-8555-17DF0A0DE274Q37620987-2009DD25-DA75-4BDF-87AE-678475D82372Q37652820-856D9674-60FF-4973-805A-2087D0758E1FQ37834294-838BE1BB-0ED6-428F-B216-7DBD190BD024Q38188467-B71703A8-FD9D-49B0-8435-2360DCD3236AQ38213375-57179C40-1B19-4FB8-A069-69D2D9EBC576Q40184920-44CDC715-493C-4B5F-976F-89C32260D5FF
P2860
Randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in Europe, Australia, and New Zealand.
description
1996 nî lūn-bûn
@nan
1996 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Randomized, double-blind, vehi ...... e, Australia, and New Zealand.
@ast
Randomized, double-blind, vehi ...... e, Australia, and New Zealand.
@en
type
label
Randomized, double-blind, vehi ...... e, Australia, and New Zealand.
@ast
Randomized, double-blind, vehi ...... e, Australia, and New Zealand.
@en
prefLabel
Randomized, double-blind, vehi ...... e, Australia, and New Zealand.
@ast
Randomized, double-blind, vehi ...... e, Australia, and New Zealand.
@en
P2093
P921
P1476
Randomized, double-blind, vehi ...... e, Australia, and New Zealand.
@en
P2093
C Apperson-Hansen
N F Kassell
P304
P356
10.3171/JNS.1996.84.2.0221
P577
1996-02-01T00:00:00Z